Volume 28, Supplement—December 2022
Effects of COVID-19 on Vaccine-Preventable Disease Surveillance Systems in the World Health Organization African Region, 2020
Global emergence of the COVID-19 pandemic in 2020 curtailed vaccine-preventable disease (VPD) surveillance activities, but little is known about which surveillance components were most affected. In May 2021, we surveyed 214 STOP (originally Stop Transmission of Polio) Program consultants to determine how VPD surveillance activities were affected by the COVID-19 pandemic throughout 2020, primarily in low- and middle-income countries, where program consultants are deployed. Our report highlights the responses from 154 (96%) of the 160 consultants deployed to the World Health Organization African Region, which comprises 75% (160/214) of all STOP Program consultants deployed globally in early 2021. Most survey respondents observed that VPD surveillance activities were somewhat or severely affected by the COVID-19 pandemic in 2020. Reprioritization of surveillance staff and changes in health-seeking behaviors were factors commonly perceived to decrease VPD surveillance activities. Our findings suggest the need for strategies to restore VPD surveillance to prepandemic levels.
Routine immunizations are among the most effective interventions to reduce illnesses, hospitalizations, and deaths from vaccine-preventable diseases (VPD) (1). The COVID-19 pandemic has directly affected services in health systems, including routine vaccine delivery, disease detection, laboratory confirmation of suspected cases, and outbreak responses (2–4). While the COVID-19 pandemic continues to disrupt routine immunization services, maintaining high-quality VPD surveillance is even more critical for detecting and responding effectively to VPD outbreaks, particularly in geographic areas with populations known to be vulnerable or low immunization coverage (5,6).
Recent assessments have suggested that COVID-19 mitigation measures (e.g., social distancing, country border lockdowns, delays in specimen transportation) may have hindered detection and timely notification of VPD cases (5,7). It is unknown if the decrease in reported surveillance indicators and cases were because of interruptions in surveillance systems, decreases in disease occurrence, or both. This lack of data includes which specific activities of VPD surveillance were most disrupted by the COVID-19 pandemic at national and subnational levels and to what extent these disruptions varied by disease, location, or severity of impact. Information from frontline workers at the operational levels of VPD surveillance systems, such as STOP Program consultants, can serve as a foundational source to identify specific surveillance components affected by the COVID-19 pandemic.
Since 1999, the STOP (originally Stop Transmission of Polio) Program has supported the Global Polio Eradication Initiative (GPEI) and national ministries of health to strengthen routine immunization and surveillance programs to reduce global VPD morbidity and mortality (8). STOP consultants are deployed through the World Health Organization (WHO) in 1 of 3 roles (communications specialist, data manager, or field epidemiologist) at national, provincial, district, and subdistrict levels (8). To help document the effect of the COVID-19 pandemic on general VPD surveillance, as well as on 3 priority surveillance systems—measles, rubella, and acute flaccid paralysis (AFP) for poliovirus—we solicited information from STOP consultants on disruptions they observed to VPD surveillance programs while deployed during 2020. We considered insights from STOP consultants relevant because of their field presence and direct involvement in immunization and VPD surveillance activities throughout the COVID-19 pandemic.
We developed a web-based survey to determine how surveillance activities across different health system levels changed because of the COVID-19 pandemic. We distributed the survey in May 2021 to all 214 STOP consultants deployed to 44 countries across the 6 WHO regions who were on assignment from January 2020 through June 2021. Our report focuses on the WHO African Region, where 75% (160/214) of all STOP consultants were deployed. The survey questions primarily focused on their perceptions and observations about how COVID-19 had affected surveillance for poliovirus, measles, rubella, and other VPDs (pertussis, yellow fever, and neonatal tetanus) and asked STOP consultants to recall changes to their work in 2020 compared with 2019. The survey, developed in both English and French, included categorical responses and free-text fields and was sent to respondents by email with 2 weeks for completion.
We used R version 9.1.3 (The R Project for Statistical Computing, https://www.r-project.org) to conduct descriptive analyses to summarize the quantitative survey findings by calculating the proportion of responses to each question. We then reviewed qualitative information provided through the free-text responses to identify trends and themes that provided more context and descriptive information about the disruptions to VPD surveillance activities observed by the STOP consultants.
Of the 160 STOP consultants in the African Region, 154 (96%) completed the survey (Table 1). Seventy percent (107/154) were epidemiologists, with 42% (64/154) stationed at the district level. All (154/154) African Region STOP consultants who responded were involved to some extent in COVID-19 activities in 2020, most often supporting response activities related to active surveillance and contact tracing; coordinating state-, district-, or local-level COVID-19 response efforts; engaging communities to implement preventive measures; and developing and disseminating COVID-19 weekly reports.
Among respondents, 97% observed that the COVID-19 pandemic either somewhat (54%; 83/154) or severely (43%; 66/154) affected measles or rubella surveillance in 2020. Themes from free-text responses suggested movement restrictions implemented to mitigate the risk of COVID-19 transmission affected the ability of surveillance staff to conduct supervisory visits, active case searches, suspected case investigations, community-based surveillance, and capacity-building activities and impeded collection and transportation of blood samples. About two thirds of the African Region STOP respondents (61%; 94/154) suggested that COVID-19 mitigation efforts also potentially disrupted the detection, notification, and reporting of measles or rubella cases.
Almost all of the African Region STOP consultants surveyed observed that AFP surveillance for poliovirus was either somewhat (55%; 84/154) or severely (43%; 66/154) affected by the COVID-19 pandemic during 2020 (Table 2). Some respondents suggested that country lockdowns and the reassignment of polio program staff to the COVID-19 response contributed to the decrease in AFP surveillance activities in 2020. Surveillance activities delayed by COVID-19 mitigation measures commonly mentioned by respondents included active case investigations and transporting samples to national laboratories for processing.
African Region STOP consultants noted the number of active AFP surveillance activities they conducted decreased (77%; 119/154) or were not completed (8%; 13/154) in 2020 compared with 2019. Respondents also noted that lockdowns to mitigate the transmission of COVID-19 often reduced the public’s access to and use of local healthcare facilities and services, which may have allowed AFP cases to go undetected.
Most respondents felt that COVID-19 either somewhat (60%; 92/154) or severely (25%; 38/154) affected surveillance of other VPDs, such as pertussis, yellow fever, and neonatal tetanus, in 2020. Specifically, 65% (100/154) of respondents suggested that active surveillance conducted for other VPDs decreased in 2020 compared with 2019; 16% (24/154) noted they did not conduct any active surveillance for these other VPDs in 2020. However, African Region STOP consultants did observe some improvements in measles or rubella surveillance in 2020, including the integration of VPD surveillance activities into COVID-19 response activities; using phone, WhatsApp, and similar technologies for communication when field access was limited; improving community-based surveillance; and implementing VPD surveillance refresher trainings for health facility staff.
As the number of undervaccinated children increases because of disruptions in routine immunization services, understanding how VPD surveillance systems have fared during the COVID-19 pandemic becomes critical (1). Descriptions collected from WHO African Region STOP consultants support general observations that the COVID-19 pandemic adversely affected implementation of VPD surveillance activities in 2020 and that COVID-19 mitigation strategies and staff reassignments may have been substantial disrupting factors. Further efforts are needed to directly associate observations from our survey with changing trends in indicators of disease surveillance systems in the WHO African Region and across other WHO regions during 2020.
STOP consultants spend most of their time at local or district levels, and results from this survey suggest that certain VPD surveillance activities such as detection, notification, and reporting were affected primarily at those levels; however, some effect was observed on regional and national activities in many WHO African Region countries because the COVID-19 response was prioritized. Respondents also noted that measles and rubella surveillance staff were often shifted to COVID-19–related activities. In countries where staffing and funding are limited, integrating VPD surveillance functions across systems, instead of relying on standalone systems, could be a mechanism to address resource limitations, even moreso as COVID-19 becomes endemic in countries.
In addition, some respondents indicated that country lockdowns and movement restrictions contributed to delays in suspected case investigations and transportation of samples to reference laboratories. Although the Global Polio Eradication Initiative had published interim guidance on how to continue conducting polio surveillance with COVID-19 mitigation measures in place (9,10), survey responses seem to corroborate existing reports of decreased AFP surveillance indicators during the COVID-19 pandemic (7). Although AFP surveillance for poliovirus may have been adversely affected in many countries by the pandemic, it is notable that AFP surveillance systems were still able to identify circulating vaccine-derived and wild poliovirus in the African Region (11).
Among limitations in our survey, consultant-respondents were asked to respond to questions based on their personal knowledge and experience, which is likely to have varied depending on location, length of time in assignment, and type of assignment, and should be considered a collection of observations or case series. These responses provide a valuable starting point to generate hypotheses for future public health investigations and research into impacts of VPD surveillance systems during the COVID-19 pandemic. Second, each STOP consultant surveyed was contracted through WHO to work in partnership with the Ministry of Health in their country of assignment. Thus, responses might not represent observations of the COVID-19 pandemic’s effect on VPD surveillance activities among private sector or non–Ministry of Health immunization and surveillance staff, or in countries without STOP consultants.
Since 2020, the COVID-19 pandemic has disrupted or delayed many aspects of both aggregate and case-based VPD surveillance systems in Africa. A conscientious effort should be made to connect COVID-19 response activities to existing public health surveillance systems, especially where substantial investments have been made towards strengthening VPD contact tracing, active surveillance, and specimen collection and transportation. Efforts to integrate systems across diseases would promote and facilitate efficient restructuring, integration, and coordination of surveillance systems globally.
Dr. Bigouette, an Epidemic Intelligence Service officer at the Centers for Disease Control and Prevention, serves as an epidemiologist stationed with the Polio Eradication Branch and the Strategic Information and Workforce Development Branch in the Global Immunization Division within the Center for Global Health.
The authors thank all STOP consultants who took time to respond to the COVID-19 survey. We acknowledge Kathryn Banke, Chung-won Lee, and Steve Wassilak for their review of the manuscript.
- World Health Organization. Global strategy for comprehensive vaccine-preventable disease (VPD) surveillance. Geneva: World Health Organization; 2020.
- Lassi ZS, Naseem R, Salam RA, Siddiqui F, Das JK. The impact of the COVID-19 pandemic on immunization campaigns and programs: a systematic review. Int J Environ Res Public Health. 2021;18:988. DOIPubMedGoogle Scholar
- Ávila-Agüero ML, Ospina-Henao S, Pirez MC, Gentile Á, Araya S, Brea J, et al. Latin American forum on immunization services during the COVID-19 pandemic. Expert Rev Vaccines. 2021;20:231–4. DOIPubMedGoogle Scholar
- Dinleyici EC, Borrow R, Safadi MAP, van Damme P, Munoz FM. Vaccines and routine immunization strategies during the COVID-19 pandemic. Hum Vaccin Immunother. 2021;17:400–7. DOIPubMedGoogle Scholar
- Bello IM, Lebo E, Shibeshi ME, Akpan GU, Chakauya J, Masresha BG, et al. Implementation of integrated supportive supervision in the context of coronavirus 19 pandemic: its effects on routine immunization and vaccine preventable surveillance diseases indicators in the East and Southern African countries. Pan Afr Med J. 2021;38:164. DOIPubMedGoogle Scholar
- World Health Organization. Immunization coverage. 2021 [cited 2021 Dec 1]. https://www.who.int/data/gho/data/themes/topics/immunization-coverage
- Zomahoun DJ, Burman AL, Snider CJ, Chauvin C, Gardner T, Lickness JS, et al. Impact of COVID-19 pandemic on global poliovirus surveillance. MMWR Morb Mortal Wkly Rep. 2021;69:1648–52. DOIPubMedGoogle Scholar
- Centers for Disease Control and Prevention. Stop Transmission of Polio (STOP) Program. 2021 [cited 2021 Dec 1]. https://www.cdc.gov/globalhealth/immunization/stop/index.htm
- Global Polio Eradication Initiative. Delivering on a promise: GPEI strategy 2022–2026. 2021 [cited 2021 Dec 1]. https://polioeradication.org/gpei-strategy-2022-2026
- World Health Organization & Global Polio Eradication Initiative. Interim guidance for the poliomyelitis (polio) surveillance network in the context of coronavirus disease (COVID-19), May 2020. Geneva: World Health Organization; 2020. Report no. WHO/POLIO/20.04.
- Rachlin A, Patel JC, Burns CC, Jorba J, Tallis G, O’Leary A, et al. Progress toward polio eradication—worldwide, January 2020–April 2022. MMWR Morb Mortal Wkly Rep. 2022;71:650–5. DOIPubMedGoogle Scholar
TablesCite This Article
Original Publication Date: September 27, 2022
Table of Contents – Volume 28, Supplement—December 2022
|EID Search Options|
|Advanced Article Search – Search articles by author and/or keyword.|
|Articles by Country Search – Search articles by the topic country.|
|Article Type Search – Search articles by article type and issue.|
Please use the form below to submit correspondence to the authors or contact them at the following address:
John Paul Bigouette, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H24-2, Atlanta, GA 30329-4027, USA